From: The biology and role of CD44 in cancer progression: therapeutic implications
CD44 isoforms | Biological functions | Cancer types | References |
---|---|---|---|
CD44s | Tumor growth, metastasis, low survival rate | Pancreatic cancer | [13] |
CD44s | Progression | Breast cancer | [54] |
CD44v3 | Migration, overexpressed in tumor tissue | Head and neck squamous cell carcinoma | [80] |
CD44v3 | Proliferation and cisplatin resistance | Head and neck squamous cell carcinoma | [81] |
CD44v4, CD44v5 | Lung metastasis loci | Pancreatic cancer | [68] |
CD44v6 | Metastasis; association with liver metastasis | Pancreatic cancer | |
CD44v6 | Epithelial phenotype cells expression | Prostate cancer | [75] |
CD44v6 | Tumorigenic and chemoresistance | Prostate cancer | [57] |
CD44v6 | Migration, metastasis, advanced stage of tumor | Colorectal adenocarcinomas | |
CD44v6 | Metastasis | Colon cancer | [15] |
CD44v6,CD44v9 | Correlates with lymph node metastasis, liver metastasis, and TNM stage | Pancreatic cancer | [56] |
CD44v9 | Lower survival rate, correlates with lymph node/liver metastasis, and TNM stage | Pancreatic cancer | [56] |
CD44v9 | Associated with worse prognosis, contributed to EMT-mediated invasion and migration | Bladder cancer | [200] |
CD44v9 | Inhibited assembly of p-cMet, AR, HSP90, P110α/PI3K, and CD44 into lipid raft like structures | Prostate cancer | [76] |
CD44v4-10 | Promoted adenoma initiation in Apc(Min/+)mice, tumor initiation | Colorectal cancer | [88] |
CD44v8-10 | Tumor initiation | Gastric cancer | [89] |
CD44v8-10 | Lung metastasis | Breast cancer | [70] |
CD44v (v6-10,v7-10,v8-10) | Correlative study of CD44v expression on transgenic Gan mice | Gastric tumor | [86] |
CD44v8-10 overexpression | Enhance chronic phase CML progenitor replacing capacity | Leukemia | [201] |
CD44, isoforms not specified | Correlative study of CD44 expression on malignant stage | Prostate cancer | [73] |
CD44, isoforms not specified | Increased colony formation, invasion | Prostate cancer | [79] |
CD44, isoforms not specified | Poor prognosis, low survival rate, metastasis | Pancreatic cancer | [69] |